Enlivex(DE:1BT)
€0.99-0.07 (-6.60%)
DE:1BT
Enlivex stock drug pipeline
€0.99
At close:-0.07 (-6.60%)
Enlivex (1BT) Drug Pipeline
0 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Enlivex Therapeutics (DE:1BT) have in its pipeline
Enlivex DE:1BT is currently developing the following drugs: Allocetra, Allocetra-Ots. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

